The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 727 KB) and Technical Notes (PDF, 1.1 MB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 2.7

U.S. Childhood Cancer Survivors at January 1, 2018
Number of People Previously Diagnosed with Cancer as Children (Ages 0-19 Years) in the United States and Alive January 1, 2018
By International Classification of Childhood Cancer (ICCC)a Selected Group and Subgroup, Age Group, and Sex

Site Sex Complete Prevalence Counts by Age at Prevalence All Ages
Ages
0-19		 Ages
20-29		 Ages
30-39		 Ages
40-49		 Ages
50-59		 Ages
60+		 All Ages Diagnosed
between
1992-2017		 Diagnosed
before 1992
Count Percentb
All Sites Both 129,438 109,940 87,134 72,029 50,019 34,479 483,039 294,469 188,570 39
Male 69,706 57,472 39,284 25,384 18,154 15,022 225,022 155,179 69,843 31
Femalec 59,732 52,468 47,850 46,645 31,865 19,457 258,017 139,290 118,727 46
I Leukemia Both 43,371 28,353 15,979 11,314 6,328 1,661 107,006 78,538 28,468 27
Male 23,841 15,620 7,865 5,011 2,622 640 55,599 43,350 12,249 22
Female 19,530 12,733 8,114 6,303 3,706 1,021 51,407 35,188 16,219 32
Acute lymphocytic leukemiad Both 35,121 22,738 14,230 9,619 3,895 250 85,853 61,186 24,667 29
Male 19,232 12,732 7,377 4,974 2,012 153 46,480 34,625 11,855 26
Female 15,889 10,006 6,853 4,645 1,883 97 39,373 26,561 12,812 33
I(b) Acute myeloid leukemia Both 5,075 3,400 2,264 1,856 1,367 888 14,850 9,878 4,972 33
Male 2,705 1,730 1,103 825 663 438 7,464 5,158 2,306 31
Female 2,370 1,670 1,161 1,031 704 450 7,386 4,720 2,666 36
II(a) Hodgkin lymphoma Both 4,318 10,086 8,095 7,619 6,810 3,923 40,851 23,789 17,062 42
Male 2,511 5,394 3,897 3,648 3,390 1,940 20,780 12,229 8,551 41
Female 1,807 4,692 4,198 3,971 3,420 1,983 20,071 11,560 8,511 42
II(b,c,e) Non-Hodgkin lymphoma Both 7,599 8,196 5,475 3,127 2,338 2,242 28,977 20,687 8,290 29
Male 5,139 5,482 3,445 1,595 1,145 1,249 18,055 13,782 4,273 24
Female 2,460 2,714 2,030 1,532 1,193 993 10,922 6,905 4,017 37
III CNS and misc intracranial & intraspinal neoplasms Both 20,861 16,218 13,336 9,311 6,965 4,184 70,875 43,954 26,921 38
Male 11,252 8,609 6,535 4,400 3,042 1,888 35,726 23,526 12,200 34
Female 9,609 7,609 6,801 4,911 3,923 2,296 35,149 20,428 14,721 42
IV Neuroblastoma & other peripheral nervous cell tumor Both 9,642 3,802 2,419 3,011 2,047 1,649 22,570 13,329 9,241 41
Male 4,936 1,977 815 1,104 658 456 9,946 6,862 3,084 31
Female 4,706 1,825 1,604 1,907 1,389 1,193 12,624 6,467 6,157 49
VI Renal tumors Both 7,891 4,871 7,488 7,429 4,378 2,462 34,519 12,892 21,627 63
Male 3,615 2,149 4,218 4,069 2,430 1,415 17,896 5,785 12,111 68
Female 4,276 2,722 3,270 3,360 1,948 1,047 16,623 7,107 9,516 57
VIII Malignant bone tumors Both 4,084 4,487 3,824 3,993 3,465 2,354 22,207 12,148 10,059 45
Male 2,339 2,659 2,229 1,921 1,752 1,178 12,078 7,182 4,896 41
Female 1,745 1,828 1,595 2,072 1,713 1,176 10,129 4,966 5,163 51
VIII(a) Osteosarcoma Both 2,258 2,546 2,103 1,997 1,759 1,406 12,069 6,835 5,234 43
Male 1,247 1,405 1,219 905 896 704 6,376 3,851 2,525 40
Female 1,011 1,141 884 1,092 863 702 5,693 2,984 2,709 48
VIII(c) Ewing tumor & related sarcomas of bone Both 1,451 1,386 1,044 830 756 536 6,003 3,790 2,213 37
Male 870 898 640 436 376 202 3,422 2,370 1,052 31
Female 581 488 404 394 380 334 2,581 1,420 1,161 45
IX Soft tissue & other extraosseous sarcomas Both 7,456 6,786 5,520 4,813 5,885 9,840 40,300 18,253 22,047 55
Male 4,256 3,550 2,698 2,011 3,237 6,265 22,017 9,835 12,182 55
Female 3,200 3,236 2,822 2,802 2,648 3,575 18,283 8,418 9,865 54
X Germ cell & trophoblastic tumors & neoplasms of gonads Both 5,392 9,465 7,980 7,249 7,621 11,592 49,299 22,663 26,636 54
Male 2,802 6,134 4,784 4,170 4,221 5,632 27,743 14,055 13,688 49
Female 2,590 3,331 3,196 3,079 3,400 5,960 21,556 8,608 12,948 60

Footnotes:

a International Classification of Childhood Cancer is based on ICD-O-3. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, Third Edition. Cancer. April 1, 2005: Vol 103, No. 7 , pg 1457-1467.

b Percent diagnosed before 1992 of all ages complete prevalence counts.

c All sites females excludes breast cancer.

d SEER site recode Acute Lymphocytic Leukemia was used instead of the ICCC classification lymphocytic leukemia (Ia) because of statistical modeling requirements. For more information regarding the modeling of the prevalence estimates, see Mariotto et al. Long-Term Survivors of Childhood Cancers in the United States. Cancer Epidemiol Biomarkers Prev 2009, page 1034.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.